On the occasion of the Artificial Intelligence Appreciation Day, a conference will be held at the Champalimaud Foundation aimed at bridging the gap between AI innovation and its implementation in medical practice.
The goal of the MEDICA AI - The Conference, which will take place on July 16 at the Champalimaud Foundation (FC), is to familiarise healthcare professionals, with the latest AI tools so that they can apply them in their daily practice for the benefit of patients.
21 May 2024
The images created during the daily scientific and medical endeavours at the Champalimaud Foundation can be as beautiful and compelling as any work of art. To the untrained eye, these images might also appear baffling, but, if you know what you’re looking at, they may just reveal information that can spark discoveries, contribute to the improvement of patient quality of life and maybe even alter our understanding of reality.
14 May 2024
The images created during the daily scientific and medical endeavours at the Champalimaud Foundation can be as beautiful and compelling as any work of art. To the untrained eye, these images might also appear baffling, but, if you know what you’re looking at, they may just reveal information that can spark discoveries, contribute to the improvement of patient quality of life and maybe even alter our understanding of reality.
30 Apr. 2024
We are seeking a detail-oriented and proactive Technical Assistant to provide comprehensive support to the Director of Translational Research Botton-Champalimaud Pancreatic Cancer Centre. This role will involve assisting with various administrative tasks, managing schedules, and providing specialized support for ethics/grant applications, and research-related activities.
The selected candidate will
04 Apr. 2024
THIS RECRUITMENT PROCESS IS CLOSED.
Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Research Technician to join our team at the Champalimaud Research Programme.
This meeting collaboration between the Association for Cancer Immunotherapy CIMT and the Champalimaud Foundation will address promising paths towards effective cellular treatment modalities for patients with solid cancer and discuss the boundaries of synthetically engineered immune cells. The meeting will also discuss the innovation gap between academic and small biotech driven research, and the challenges of safe, biologically, and clinically relevant phase I / II clinical trials.
Nuno Prego Ramos, co-founder and CEO of CellmAbs, will share the journey of CellmAbs, from it's early days starting with an initial technology from NOVA University to becoming a pioneering force in cancer therapy innovation.
In this talk, we will hear about the strategic decisions, challenges and breakthroughs that propelled the company to its selling the assets to the pharmaceutical giant, BioNTech.
02 May 2024
“When I explain to my friends and family the rigorous regulations in place to ensure ethical treatment of experimental animals, they seem surprised.
It is important that people know that researchers that use animals are obliged to have appropriate qualifications and training. That scientific projects are evaluated to ensure that the use of animals is needed, beneficial and that no unnecessary harm is inflicted. And that the highest standards of housing conditions must be provided by the facilities where animals are housed.